 |
 |
|
|
|
| Tamoxifen Citrate (Nolvadex) |
 |
| Nolvadex，Tamoxifen Citrate |
 |
Applied to the treatment of advanced, recurrent breast cancer and ovarian cancer.
|
 |
Tamoxifen Citrate (Nolvadex)
Product Name: Tamoxifen Citrate (Nolvadex)
Synonyms: 1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate
NOLVADEX
TAMOXIFEN CITRATE
TAMOXIFEN CITRATE SALT
Z-1-(P-DIMETHYLAMINOETHOXYPHENYL)-1,2-DIPHENYL-1-BUTENE CITRATE
(Z)-2-[4-(1,2-DIPHENYL-1-BUTENYL)PHENOXY]-N,N-DIMETHYLETHANAMINE CITRATE
(z)-2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethylethanamine,citrate(1:
(z)-2-(para-(1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethylethylaminecitrate(
2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethyl-ethanamin(z)-ethanamin2-hydrox
ici46,474
kessar
noltam
tamofen
tamoxasta
terimon
trans-1-(p-beta-dimethylaminoethoxyphenyl)-1,2-diphenylbut-1-enecitrate
y-1,2,3-propanetricarboxylate(1:1)
z-tamoxifencitrate
CAS No.: 54965-24-1
EINECS No.: 259-415-2
Molecular Formula: C32H37NO8
Molecular Weight: 563.64
Melting point: 140-144 °C
Appearance: white crystalline powder
Standard: Enterprise Standard
Packing: 25KG/Drum or as per your requirements
Application: Applied to the treatment of advanced, recurrent breast cancer and ovarian cancer.
Storage Condition: 2-8°C
Catagory: Active Pharmaceutical Ingredients
Antitumors for Research and Experimental Use
Biochemistry
API's
Intracellular receptor
pharmaceutical raw material
Steroid and Hormone
API
SOLTAMOX
antineoplastic drug
ycgl18 at yccreate dot com |
|
|
|
|
|
